Effects of Allopurinol on Endothelial Function: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

[1]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[2]  H. Park,et al.  Hyperuricemia and risk of increased arterial stiffness in healthy women based on health screening in Korean population , 2017, PloS one.

[3]  C. Borghi,et al.  Serum Uric Acid and Cardiometabolic Disease: Another Brick in the Wall? , 2017, Hypertension.

[4]  C. Borghi,et al.  Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study , 2017, Annals of medicine.

[5]  A. Advani,et al.  Renal and Vascular Effects of Uric Acid Lowering in Normouricemic Patients With Uncomplicated Type 1 Diabetes , 2017, Diabetes.

[6]  J. Singh,et al.  Allopurinol and the risk of ventricular arrhythmias in the elderly: a study using US Medicare data , 2017, BMC Medicine.

[7]  M. Chonchol,et al.  Vascular Function and Uric Acid-Lowering in Stage 3 CKD. , 2017, Journal of the American Society of Nephrology : JASN.

[8]  J. Mu,et al.  The Role of Uric Acid in Hypertension of Adolescents, Prehypertension and Salt Sensitivity of Blood Pressure , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[9]  C. Borghi,et al.  An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia , 2017, Vascular health and risk management.

[10]  Carolina Muscoli,et al.  Regulation of uric acid metabolism and excretion. , 2016, International journal of cardiology.

[11]  D. Hyndman,et al.  Urate Handling in the Human Body , 2016, Current Rheumatology Reports.

[12]  A. Dominiczak,et al.  Allopurinol and Cardiovascular Outcomes in Adults With Hypertension , 2016, Hypertension.

[13]  H. Kumar.  Cardiometabolic Risks and Obesity in the Young. , 2016, The New England journal of medicine.

[14]  F. Ortega,et al.  Cardiometabolic Risks and Obesity in the Young. , 2016, The New England journal of medicine.

[15]  A. Struthers,et al.  A Randomized Controlled Trial of Allopurinol in Patients With Peripheral Arterial Disease , 2016, The Canadian journal of cardiology.

[16]  J. Skelton,et al.  Cardiometabolic Risks and Obesity in the Young. , 2016, The New England journal of medicine.

[17]  L. Lerman,et al.  Prognostic Value of Flow‐Mediated Vasodilation in Brachial Artery and Fingertip Artery for Cardiovascular Events: A Systematic Review and Meta‐Analysis , 2015, Journal of the American Heart Association.

[18]  K. Tsuchiya,et al.  Febuxostat improves endothelial function in hemodialysis patients with hyperuricemia: A randomized controlled study , 2015, Hemodialysis international. International Symposium on Home Hemodialysis.

[19]  V. Aboyans,et al.  The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. , 2015, Atherosclerosis.

[20]  F. D. de Abajo,et al.  Allopurinol use and risk of non-fatal acute myocardial infarction , 2015, Heart.

[21]  L. Abenhaim,et al.  Impact of allopurinol on risk of myocardial infarction , 2014, Annals of the rheumatic diseases.

[22]  C. Borghi,et al.  Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study , 2014, Journal of hypertension.

[23]  Benjamin R. Szwejkowski,et al.  159 ALLOPURINOL REDUCES LEFT VENTRICULAR MASS IN PATIENTS WITH TYPE 2 DIABETES AND LEFT VENTRICULAR HYPERTROPHY , 2013, Heart.

[24]  Xiaorong Bao,et al.  Effects of uric acid on endothelial dysfunction in early chronic kidney disease and its mechanisms , 2013, European Journal of Medical Research.

[25]  D. Mikhailidis,et al.  Hyperuricaemia: more than just a cause of gout? , 2013, Journal of cardiovascular medicine.

[26]  E. Kopel,et al.  Association of serum uric acid and cardiovascular disease in healthy adults. , 2013, The American journal of cardiology.

[27]  C. Borghi.  Uric acid as a cross-over between rheumatology and cardiovascular disease , 2013, Current medical research and opinion.

[28]  Michael Borenstein,et al.  Meta-Analysis and Subgroups , 2013, Prevention Science.

[29]  Benjamin R. Szwejkowski,et al.  High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease. , 2013, Journal of the American College of Cardiology.

[30]  B. Afşar,et al.  The role of uric acid in the pathogenesis of human cardiovascular disease , 2013, Heart.

[31]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .

[32]  Amir Lerman,et al.  The Assessment of Endothelial Function: From Research Into Clinical Practice , 2012, Circulation.

[33]  Xian-liang Zhou,et al.  Meta-analysis of the effects of statin therapy on endothelial function in patients with diabetes mellitus. , 2012, Atherosclerosis.

[34]  C. Lang,et al.  Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. , 2011, Journal of the American College of Cardiology.

[35]  A. Dogan,et al.  Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients , 2011, Blood pressure.

[36]  A. Kapoor.  Allopurinol Benefits Left Ventricular Mass and Endothelial Dysfunction in Chronic Kidney Disease , 2011 .

[37]  C. Vlachopoulos,et al.  Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins. A systematic review and meta-analysis. , 2011, Atherosclerosis.

[38]  M. Dimopoulos,et al.  Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress. , 2011, Atherosclerosis.

[39]  Duk-Hee Kang,et al.  Oxidative stress with an activation of the renin–angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction , 2010, Journal of hypertension.

[40]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[41]  M. Walters,et al.  Allopurinol Use Yields Potentially Beneficial Effects on Inflammatory Indices in Those With Recent Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled Trial , 2008, Stroke.

[42]  Duk-Hee Kang,et al.  Uric acid and cardiovascular risk. , 2008, The New England journal of medicine.

[43]  G. Şener,et al.  Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome , 2008, Clinical Research in Cardiology.

[44]  B. Grant,et al.  Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study , 2006, European Respiratory Journal.

[45]  In-kyu Lee,et al.  Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. , 2005, Journal of the American Society of Nephrology : JASN.

[46]  D. Mikhailidis,et al.  Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia. , 2005, Current pharmaceutical design.

[47]  E. Yıldırım,et al.  Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults , 2005, International journal of clinical practice.

[48]  Thomas R. Riley,et al.  A Randomized Double-blind Placebo-controlled Trial , 2004 .

[49]  James E. Evans,et al.  Molecular identification of a danger signal that alerts the immune system to dying cells , 2003, Nature.

[50]  Alex J. Sutton,et al.  Methods for Meta-Analysis in Medical Research , 2000 .

[51]  S Duval,et al.  Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis , 2000, Biometrics.

[52]  S D Walter,et al.  The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. , 1997, Journal of clinical epidemiology.

[53]  M. Netea,et al.  The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. , 1997, Blood.

[54]  R. Jaques,et al.  The anti-inflammatory action of a xanthine oxidase inhibitor (allopurinol). , 1969, Pharmacology.